Discover 482 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 482
Differential Thrombogenesis by EPA and DHA Mediated by HDL
for
Lipid Metabolism Disorders, Hypertriglyceridemia
Location: Providence RI
Sponsor: The Miriam Hospital
Sex: All
Age: 18 - 69
Code: NCT06494488
Early_phase1, Recruiting
Contraceptive Awareness and Reproductive Education
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
for
Type2Diabetes, ASCVD
Location: Pawtucket RI, Worcester MA, Boston MA, New York NY,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 40 - 70+
Code: NCT05390892
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
for
Mild Cognitive Impairment, Alzheimer's Disease,
Location: East Providence RI, Toronto, Farmington Hills MI,
Sponsor: GAP Innovations, PBC
Sex: All
Age: 60 - 70+
Code: NCT06584357
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: East Providence RI, New Bedford MA, Worcester MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island
for
Breast Cancer, Colorectal Cancer, Covid19
Location: Pawtucket RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT04587258
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: East Providence RI, Boston MA, Bloomfield CT,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: East Providence RI, Roxbury MA, Boston MA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews
for
Opioid Use Disorder, Criminal Justice,
Location: Cranston RI
Sponsor: Lifespan
Sex: All
Age: 18+
Code: NCT06354465
Recruiting
Injectable Buprenorphine in Prison: A Preference Trial
for
Opioid Use Disorder, Incarceration,
Location: Cranston RI
Sponsor: Lifespan
Sex: All
Age: 18+
Code: NCT06880718
Recruiting
Implementing Low-Barrier HCV Treatment in a Jail Setting
for
HEPATITIS C (HCV), Incarceration, Injection Drug Use,
Location: Cranston RI
Sponsor: Lifespan
Sex: All
Age: 18+
Code: NCT06953479
Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
for
Eosinophilic Asthma
Location: Warwick RI, New Hyde Park NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 70+
Code: NCT06750289
Phase3, Recruiting
Bucillamine Phase 2 Trial in Patients With Cystinuria
for
Cystinuria
Location: Warwick RI, Boston MA, New York NY, Madison WI,
Sponsor: Revive Therapeutics, Ltd.
Sex: All
Age: 18 - 70+
Code: NCT02942420
Phase2, Recruiting
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Warwick RI, New York NY, Glenn Dale MD, Pittsburgh PA,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07143669
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Warwick RI, Portsmouth NH, Falls Church VA,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
for
Locally Advanced Pancreatic Adenocarcinoma
Location: Providence RI, Boston MA, Philadelphia PA,
Sponsor: EXACT Therapeutics AS
Sex: All
Age: 18+
Code: NCT06850623
Phase2, Recruiting
New
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: East Greenwich RI, Trenton NJ, Manassas VA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase3, Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Canton OH,